Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of May 20, 2026, NTRA trades at $205.88 with a market cap of $27.57B and a P/E ratio of -124.56. NTRA moved +4.51% today. Year to date, NTRA is -13.69%; over the trailing twelve months it is +32.61%. Its 52-week range spans $117.27 to $256.36. Analyst consensus is strong buy with an average price target of $262.14. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NTRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NTRA recently traded at $205.88. Market cap is $27.57B. P/E ratio is -124.56. Revenue is $2.50B.
| Metric | Value |
|---|---|
| Price | $205.88 |
| Market Cap | $27.57B |
| P/E Ratio | -124.56 |
| EPS | $-1.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $256.36 |
| 52-Week Low | $117.27 |
| Volume | 1.33M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.50B |
| Net Income | $-226.31M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.31B | $-208.16M | $-1.52 |
| 2024 | $1.70B | $-190.43M | $-1.53 |
| 2023 | $1.08B | $-434.80M | $-3.78 |
| 2022 | $820.22M | $-547.80M | $-5.57 |
16 analysts cover NTRA: 0 strong buy, 15 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $262.14.